GHTM

Global Health and Tropical Medicine

  • GHTM
    • Vision
    • Mission
    • Governance
    • Scientific Advisory Board
  • News
    • Outreach
    • Events
      • GHTM Sessions
      • Workshops
    • Articles
    • Jobs
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases and pathogens
      • IHC – Individual health care
    • Research in numbers
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases and pathogens
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Technical / administrative support
  • Publications
  • Education
    • Master Theses
    • PhD Theses
  • Services
Home / Publicações / The Role of Reservoirs: Canine Leishmaniasis

The Role of Reservoirs: Canine Leishmaniasis

  • Autores: Campino L, Maia C
  • Ano de Publicação: 2018
  • Journal: Drug Resistance in Leishmania Parasites
  • Link: https://link.springer.com/chapter/10.1007/978-3-319-74186-4_3

Canine leishmaniasis caused by Leishmania (Leishmania) infantum species (syn. L. (L.) chagasi species in Latin America), which is transmitted by the bite of phlebotomine sand flies, is endemic and affects millions of dogs in Asia, Europe, North Africa, and South America and is considered as an emergent disease in North America. Domestic dogs (Canis familiaris) are the major hosts for these parasites and the main reservoir host for human infection.

Recent years have seen important advances on the epidemiology, pathology, and canine genetic factors linked with animal resistance or susceptibility to leishmaniasis. Despite the lack of pathognomonic manifestations, infection by Leishmania can be suspected if a combination of clinical signs is present, namely, lymphadenomegaly, cutaneous alterations, loss of body weight, ocular disturbs, epistaxis, onychogryphosis, and lameness. However, the definitive diagnosis of canine leishmaniasis is complex since not all infected animals develop signs of disease. This fact cannot be ignored since asymptomatic (without clinical signs) dogs are infectious to phlebotomine vectors, although at a lower risk than symptomatic (with clinical signs) dogs. The fact that dogs never achieve parasitological cure together with the widespread use of the available anti-Leishmania drugs for both canine and human treatment certainly contributes to the spread of drug-resistant parasites with the natural consequences for the clinical outcome of the disease.

Early detection of infection and close surveillance or treatment of infected animals together with the development of effective molecules for therapy (ideally different from the ones used for humans) and, more importantly, for immunoprophylaxis are essential to control the dissemination of the disease among other dogs, being also a crucial element for the control of human zoonotic leishmaniasis.

This chapter reviews the role of dogs as reservoir hosts of L. (L.) infantum and as accidental hosts of other Leishmania species, as well as the role of other mammals as potential reservoir hosts of parasites belonging to the L. (L.) donovani complex. The potential generation and spread of drug resistance by the use of the same compounds in both canine and human hosts are also discussed.

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to print (Opens in new window)

Events

NOVA Sciencepreneur program: registration is open

  The Sciencepreneur ® program is aimed at NOVA scientists who are seeking to create value … [Read More...]

IHMT selected for the pilot phase of the Research Data Repository Service of the FCT

  In order to promote good practices in Open Science with regard to research data and … [Read More...]

Paulo Ferrinho interviewed for the new e-magazine of European and Developing Countries Clinical Trials Partnership (EDCTP)

Paulo Ferrinho, professor and Diretor of Public Global Health Departament at the Instituto de … [Read More...]

How can we improve the environmental performance of our laboratories?

  Every day in NOVA's laboratories research is carried out with the consumption of numerous … [Read More...]

Call for PhD Studentships

The Institute of Hygiene and Tropical Medicine (IHMT), Universidade Nova de Lisboa (NOVA), through … [Read More...]

IHMT | GHTM – APPLICATIONS ARE OPEN!

IHMT | GHTM - Applications are open for three research vacancies:   One position - PhD … [Read More...]

About GHTM

GHTM is a R&D Center that brings together researchers from IHMT with a track record in Tropical Medicine and International/Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal
+351 213 652 600
+351 213 632 105

  • Facebook
  • YouTube

Subscribe Newsletter

  • How to get to GHTM/IHMT
  • GHTM Sessions
  • Research Groups
  • Cross-cutting issues
© Copyright 2023 IHMT-UNL Todos os Direitos Reservados.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    Project UID/Multi/04413/2013